| Announce Date | 02/04/2026 |
| EPS Normalized Actual | $0.581 (Miss by $-0.249) |
| EPS GAAP Actual | $0.581 (Miss by $-0.249) |
| Revenue Actual | $1.0271B |
| Revenue Surprise | Beat by $1027.1M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2030 | 4.39 | 13.69 | 4.30025 | 4.43827 | 6 |
| Dec 2029 | 0 | INF | 0 | 0 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.17 | 0.17 | 1.0271B | -49.41% | 1027.1M |
| FQ2 2025 (Jun 2025) | 0.49 | 0.49 | 1.5188B | -2.21% | 1518.8M |
| FQ1 2025 (Mar 2025) | 0.5 | 0.5 | 1.4742B | -3.41% | 1474.2M |
| FQ4 2024 (Dec 2024) | 0.61 | 0.61 | 1.6203B | 41.52% | 1620.3M |
| FQ3 2024 (Sep 2024) | 0.63 | 0.63 | 1.5346B | 2.61% | 1534.6M |
| FQ2 2024 (Jun 2024) | 0.56 | 0.56 | 1.5524B | 1.67% | 1552.4M |
| FQ1 2024 (Mar 2024) | 0.59 | 0.59 | 1.5245B | 4.18% | 1524.5M |
| FQ4 2023 (Dec 2023) | 0.75 | 0.75 | 0.9475B | -61.47% | 947.5M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.82 | -- | 0.80856 | 0.83452 | 1 |
| FQ3 2027 (Sep 2027) | 0.7 | -- | 0.69024 | 0.7124 | 1 |
| FQ2 2027 (Jun 2027) | 0.68 | -- | 0.67052 | 0.69204 | 1 |
| FQ1 2027 (Mar 2027) | 0.66 | -- | 0.6508 | 0.67169 | 1 |
| FQ4 2026 (Dec 2026) | 0.8494 | -- | 0.83755 | 0.86445 | 1 |
| FQ3 2026 (Sep 2026) | 0.71954 | 76.37 | 0.70951 | 0.73229 | 1 |
| FQ2 2026 (Jun 2026) | 1.0919 | 55.12 | 1.08 | 1.10435 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.19B | -- | 1.17B | 1.2B | 1 |
| FQ3 2027 (Sep 2027) | 1.11B | -- | 1.1B | 1.12B | 1 |
| FQ2 2027 (Jun 2027) | 1.09B | -- | 1.07B | 1.1B | 1 |
| FQ1 2027 (Mar 2027) | 1.06B | -- | 1.05B | 1.07B | 1 |
| FQ4 2026 (Dec 2026) | 1.13B | -- | 1.12B | 1.15B | 1 |
| FQ3 2026 (Sep 2026) | 1.06B | 3.13 | 1.05B | 1.07B | 1 |
| FQ2 2026 (Jun 2026) | 1.72B | 11.76 | 1.71B | 1.74B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.17 | 0.17 | 100% | |
| FQ2 2025 (Jun 2025) | 0.49 | 0.49 | 100% | |
| FQ1 2025 (Mar 2025) | 0.5 | 0.5 | 100% | |
| FQ4 2024 (Dec 2024) | 0.61 | 0.61 | 100% | |
| FQ3 2024 (Sep 2024) | 0.63 | 0.63 | 100% | |
| FQ2 2024 (Jun 2024) | 0.56 | 0.56 | 100% | |
| FQ1 2024 (Mar 2024) | 0.59 | 0.59 | 100% | |
| FQ4 2023 (Dec 2023) | 0.75 | 0.75 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $1.03B | $1027.1M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $1.52B | $1518.8M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1.47B | $1474.2M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.62B | $1620.3M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.53B | $1534.6M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.55B | $1552.4M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.52B | $1524.5M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.95B | $947.5M | 100% |